Trial intelligence / Profile preview

N-acetylcysteine premedication before upper gastrointestinal endoscopy

ChiCTR1800015281Phase 4Not yet recruiting

Sponsor
Beijing Friendship Hospital
Start
Apr 2018
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of acetylcysteine, pronase, simethicone and lidocaine in Upper gastrointestinal tract cancer (4 arms), sponsored by Beijing Friendship Hospital. Primary endpoints: Score of gastric body, Score of fundus and 1 more. Planned start Apr 2018; status: not yet recruiting.

02

Drugs

acetylcysteinepronasesimethiconelidocaine
03

Conditions

Upper gastrointestinal tract cancer

Beyond the preview

Go deeper on ChiCTR1800015281.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800015281.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call